tau oligomerization inhibitors (Treventis/University of Toronto)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametau oligomerization inhibitors (Treventis/University of Toronto)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTreventis Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of TorontoTreventis Corp
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A